Llwytho...
Testosterone therapy and prostate cancer
The use of exogenous testosterone to treat hypogonadism in the men with a history of prostate cancer (CaP) remains controversial due to fears of cancer recurrence or progression. Due to the detrimental impact of hypogonadism on patient quality of life, recent work has examined the safety of testoste...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Transl Androl Urol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182214/ https://ncbi.nlm.nih.gov/pubmed/28078223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.08.17 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|